ARCHIVES

FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays

This article is from The Cancer Letter archive.

Vol. 01 No. 49 | December 5, 1975

Download PDF Visit The Full Archive

Related Articles

Moratorium Asked On New Bladder Cancer Screening

January 27, 1978

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

In Brief: Bernard Fisher Professorship Endowed By ICI Pharma; Brady Wins RSNA Medal

January 5, 1990

NCI Relates FDA Instructions On Latest IND Delays

October 29, 1976

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012